The global neuroprosthetics market is expected to reach $14 billion by 2020, Finds New Report, New Report Launched

"Global Neuroprosthetics Market (Product Types, Technology, Application, and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020", the global neuroprosthetics market is expected to reach $14 billion by 2020, registering a CAGR of 15.8% from 2014 to 2020.

High growth segments such as Visual neuroprosthetics/retinal implants and applications such as Parkinson's disease, Overactive Bladder Syndrome and Epilepsy are expected to contribute substantially to the growth of the overall global Neuroprosthetics market. Motor Prosthetics holds the largest share within Neuroprosthetics devices market segment whereas Sacral Cord Stimulation (SCS) would maintain the leading market position through 2020, within technology segment.Multitude of cognitive and physiological disorders have a debilitating impact on 'quality-of-life' of affected patient populace.

A majority (~80%) of such patients are unamenable to any form of treatment as first line (drug) and second line (invasive surgeries) treatments fail. Neuroprosthetics devices or neural implants or brain implants offer an efficacious solution to the afore-mentioned type of patients. Neuroprosthetics deploy technologies such as Deep Brain Simulation (DBS), Vagus Nerve Stimulation (VNS), Spinal Cord Stimulation (SCS) and Sacral Nerve Stimulation (SNS) depending on the clinical condition to ameliorate the disease condition. Depending on the condition treated, product types of Neuroprosthetics include Motor Prosthetics, Auditory Prosthetics/ Cochlear Implants, Visual Prosthetics/ Retinal implants and Cognitive Prosthetics.

Owing to various factors such as high base of affected patient population, the patient population amenable to Neuroprosthetics and scope of improvement in QALY, the Motor Neuroprosthetics market for treating Parkinson's disease garners the largest market share; Motor Neuroprosthetics for treating Overactive Bladder Syndrome and Motor Neuroprosthetics for treating Epilepsy are second and third largest segment respectively. Despite such benefits that are high-impact growth drivers for the market, high-cost of devices curtail the adoption rate by patients, thus restrain the market growth.

Key findings of the study:

• Global market for Neuroprosthetics gaining traction with Visual Prosthetics/ Retinal implants and Motor Neuroprosthetics (for treating Parkinson's disease) being major growth arenas during the forecast period (2014 - 2020)
• Within Neuroprosthetics devices market, Visual Prosthetics/ Retinal implants is the fastest growing segment
• Within Neuroprosthetics devices, Motor Neuroprosthetics segment would garner the largest market share, owing to numerous applications such as Parkinson's disease, Neurocardiac disorders, Over Active Bladder syndrome and Epilepsy
• North America would be the lucrative market, both in terms of market size and growth, (among all regional markets)

Spanning over 156 pages, 42 Tables and 37 Figures “Global Neuroprosthetics Market (Product Types, Technology, Application, and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020” report Covering Introduction, Executive Summary, Market Overview, Global Neuroprosthetics Market By Technology, 2013-2020, $Million, Global Neuroprosthetics Market By Type, 2013-2020, $Million, Global Neuroprosthetics Market By Application, 2013-2020, $Million, Global Neuroprosthetics Market By Geography, 2013-2020, $Million, Company Profiles. This report Covered These Companies - Boston Scientific Corporation, Cochlear Limited, Cyberonics Inc., Medtronic Inc., NDI Medical LLC, Nervo Corp., NeuroPace Inc, Retina Implant AG, Jude Medical, Sonova Group (Advanced Bionics AG).

Know more about this report at – http://mrr.cm/4k5

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare